Simony-Lafontaine J - Search Results

1

Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.

Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jacquemier J, Sobol H, Eisinger F, Birnbaum D. Kerangueven F, et al. Cancer Res. 1997 Dec 15;57(24):5469-74. Cancer Res. 1997. PMID: 9407952

2

Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.

Theillet C, Le Roy X, De Lapeyrière O, Grosgeorges J, Adnane J, Raynaud SD, Simony-Lafontaine J, Goldfarb M, Escot C, Birnbaum D. Theillet C, et al. Oncogene. 1989 Jul;4(7):915-22. Oncogene. 1989. PMID: 2474139

3

Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C. Courjal F, et al. Cancer Res. 1997 Oct 1;57(19):4360-7. Cancer Res. 1997. PMID: 9331099

4

Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas.

Ferrières G, Cuny M, Simony-Lafontaine J, Jacquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P, Escot C. Ferrières G, et al. J Pathol. 1997 Oct;183(2):204-11. doi: 10.1002/(SICI)1096-9896(199710)183:2<204::AID-PATH921>3.0.CO;2-M. J Pathol. 1997. PMID: 9390034

5

p53 mutations occur in aggressive breast cancer.

Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C. Mazars R, et al. Cancer Res. 1992 Jul 15;52(14):3918-23. Cancer Res. 1992. PMID: 1617667

6

Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.

Brouillet JP, Theillet C, Maudelonde T, Defrenne A, Simony-Lafontaine J, Sertour J, Pujol H, Jeanteur P, Rochefort H. Brouillet JP, et al. Eur J Cancer. 1990 Apr;26(4):437-41. doi: 10.1016/0277-5379(90)90012-i. Eur J Cancer. 1990. PMID: 2141510

7

Tumor progression and oxidant-antioxidant status.

Gerber M, Astre C, Ségala C, Saintot M, Scali J, Simony-Lafontaine J, Grenier J, Pujol H. Gerber M, et al. Cancer Lett. 1997 Mar 19;114(1-2):211-4. doi: 10.1016/s0304-3835(97)04665-x. Cancer Lett. 1997. PMID: 9103294

8

Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors.

Simony-Lafontaine J, Esslimani M, Bribes E, Gourgou S, Lequeux N, Lavail R, Grenier J, Kramar A, Casellas P. Simony-Lafontaine J, et al. Br J Cancer. 2000 Jun;82(12):1958-66. doi: 10.1054/bjoc.2000.1162. Br J Cancer. 2000. PMID: 10864204 Free PMC article.

9

Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.

Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson JA, Rochefort H. Esslimani-Sahla M, et al. Clin Cancer Res. 2004 Sep 1;10(17):5769-76. doi: 10.1158/1078-0432.CCR-04-0389. Clin Cancer Res. 2004. PMID: 15355905

10

Increased estrogen receptor betacx expression during mammary carcinogenesis.

Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson JA, Rochefort H. Esslimani-Sahla M, et al. Clin Cancer Res. 2005 May 1;11(9):3170-4. doi: 10.1158/1078-0432.CCR-04-2298. Clin Cancer Res. 2005. PMID: 15867209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters